tiprankstipranks
AngioDynamics (ANGO)
NASDAQ:ANGO
Holding ANGO?
Track your performance easily

AngioDynamics (ANGO) Ownership - Who Owns AngioDynamics?

455 Followers

AngioDynamics (ANGO) Ownership Overview

4.02%16.85%26.04%11.94%41.15%
26.04% Other Institutional Investors
11.94% ETFs
41.15% Public Companies and Individual Investors
The ownership structure of AngioDynamics (ANGO) stock is a mix of institutional, retail, and individual investors. Approximately 54.83% of the company’s stock is owned by Institutional Investors, 4.02% is owned by Insiders, and 41.15% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 10, 2024
Warren Nighan
Svp Quality And Regulatory
xxxxxxxxxxxxx
$5285
Oct 08, 2024
James Clemmer
President & Ceo,director
xxxxxxxxxxxxx
$120600
Oct 08, 2024
xxxxxxxxxxxxx
$9962
Apr 08, 2024
James Clemmer
President & Ceo,director
xxxxxxxxxxxxx
$67000

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$3066206
Sep 30, 2024
xxxxxxxxxxxxx
$7671647

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,230,736Institution5.49%15,503,615
1,807,829Institution4.45%12,564,412
1,575,361Institution3.88%10,948,759
986,073Institution2.43%6,853,207
773,736Institution1.90%5,377,465
681,582Insider1.68%4,736,995
569,410Institution1.40%3,957,400
550,579Institution1.35%3,826,524
526,266Institution1.30%3,657,549
481,044Institution1.18%3,343,256

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,807,829Institution4.45%12,564,412
773,736Institution1.90%5,377,465
569,410Institution1.40%3,957,400
550,579Institution1.35%3,826,524
481,044Institution1.18%3,343,256
441,254Institution1.09%3,066,715
332,419Institution0.82%2,310,312
297,132Institution0.73%2,065,067
224,670Institution0.55%1,561,457
181,777Institution0.45%1,263,350

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,198,947Institution2.95%8,020,955
1,038,793Institution2.56%7,219,611
655,871Institution1.61%4,387,777
363,532Institution0.89%2,526,547
219,768Institution0.54%1,481,236
192,901Institution0.47%1,300,153
173,932Institution0.43%1,163,605
132,985Institution0.33%889,670
72,013Institution0.18%777,020
114,744Institution0.28%773,375

FAQ

Who Owns AngioDynamics (ANGO)?
According to the latest TipRanks data, approximately 26.04% of the company's stock is held by institutional investors, 4.02% is held by insiders, and 41.15% is held by retail investors.
    What percentage of AngioDynamics (ANGO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 26.04% of AngioDynamics (ANGO) stock is held by institutional investors.
      What percentage of AngioDynamics (ANGO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 41.15% of AngioDynamics (ANGO) stock is held by retail investors.
        Who owns the most shares of AngioDynamics (ANGO)?
        Vanguard owns the most shares of AngioDynamics (ANGO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis